Saving More Lives: TAVR Approved for Low-Risk Patients

Last summer, low-risk patients were approved for catheter-based aortic valve replacement by the FDA. That means more people can now have the minimally invasive procedure. Before this change, 80 percent of those living with this disease were considered too healthy to qualify. CHI Health had a hand in bringing this procedure to low-risk patients by serving as a clinical trial site for intermediate and low-risk patients. Now, the majority of people living with aortic valve stenosis can bypass open heart surgery and opt for a catheter-based valve replacement instead. “Really this has changed the landscape for the treatment of aortic valve stenosis,” Dr. Anu said. “It’s no more a question of who is a candidate. The question is who is not a candidate.”

Anuradha Tunuguntla, MBBS